223 related articles for article (PubMed ID: 7835170)
1. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.
Cameron NE; Cotter MA
Diabetes Metab Rev; 1994 Oct; 10(3):189-224. PubMed ID: 7835170
[No Abstract] [Full Text] [Related]
2. Vascular factors in diabetic neuropathy: comment.
Simpson LO
Diabetologia; 1995 Jul; 38(7):872-3. PubMed ID: 7556993
[No Abstract] [Full Text] [Related]
3. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
Cameron NE; Cotter MA; Dines KC; Maxfield EK
Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173
[TBL] [Abstract][Full Text] [Related]
4. Cause and effect of ischaemia in chronic experimental diabetic neuropathy.
Low P; Kihara M; Cameron N; Cotter M; Poduslo J
Diabet Med; 1993; 10 Suppl 2():52S-55S. PubMed ID: 8334844
[No Abstract] [Full Text] [Related]
5. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects.
Stevens MJ; Feldman EL; Greene DA
Diabet Med; 1995 Jul; 12(7):566-79. PubMed ID: 7554777
[TBL] [Abstract][Full Text] [Related]
6. Vascular defects in the aetiology of peripheral insulin resistance in diabetes. A critical review of hypotheses and facts.
Wiernsperger N
Diabetes Metab Rev; 1994 Oct; 10(3):287-307. PubMed ID: 7835173
[No Abstract] [Full Text] [Related]
7. Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats.
Cotter MA; Gibson TM; Nangle MR; Cameron NE
Diabetes Obes Metab; 2010 Aug; 12(8):689-99. PubMed ID: 20590746
[TBL] [Abstract][Full Text] [Related]
8. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
Cameron NE; Dines KC; Cotter MA
Diabetologia; 1994 Dec; 37(12):1209-15. PubMed ID: 7895950
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.
Greene DA; Sima AA; Stevens MJ; Feldman EL; Killen PD; Henry DN; Thomas T; Dananberg J; Lattimer SA
Diabetes Metab Rev; 1993 Oct; 9(3):189-217. PubMed ID: 8187607
[No Abstract] [Full Text] [Related]
10. Relationship between ischemia and neuropathy.
Teunissen LL; Notermans NC; Wokke JH
Eur Neurol; 2000; 44(1):1-7. PubMed ID: 10894988
[TBL] [Abstract][Full Text] [Related]
11. Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state.
van Dam PS; van Asbeck BS; Van Oirschot JF; Biessels GJ; Hamers FP; Marx JJ
Eur J Clin Invest; 2001 May; 31(5):417-24. PubMed ID: 11380593
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.
Dines KC; Cotter MA; Cameron NE
Diabetologia; 1993 Nov; 36(11):1132-8. PubMed ID: 8270127
[TBL] [Abstract][Full Text] [Related]
13. Disturbed microvascular reactivity and shunting - a major cause for diabetic complications.
Fagrell B; Jörneskog G; Intaglietta M
Vasc Med; 1999; 4(3):125-7. PubMed ID: 10512590
[No Abstract] [Full Text] [Related]
14. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes.
Cameron NE; Cotter MA
Diabetes Res Clin Pract; 1999 Sep; 45(2-3):137-46. PubMed ID: 10588366
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.
Cameron NE; Cotter MA
Diabetes; 1997 Sep; 46 Suppl 2():S31-7. PubMed ID: 9285496
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic neuropathy].
Chudzik W; Kaczorowska B; Przybyła M; Chudzik B; Gałka M
Pol Merkur Lekarski; 2007 Jan; 22(127):66-9. PubMed ID: 17477095
[TBL] [Abstract][Full Text] [Related]
17. The role of oxidative stress in diabetic vascular and neural disease.
Yorek MA
Free Radic Res; 2003 May; 37(5):471-80. PubMed ID: 12797466
[TBL] [Abstract][Full Text] [Related]
18. Endoneurial capillary abnormalities in mild human diabetic neuropathy.
Malik RA; Veves A; Masson EA; Sharma AK; Ah-See AK; Schady W; Lye RH; Boulton AJ
J Neurol Neurosurg Psychiatry; 1992 Jul; 55(7):557-61. PubMed ID: 1640230
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy.
Stevens MJ
Diabet Med; 1995 Apr; 12(4):292-5. PubMed ID: 7600740
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
Maxfield EK; Cameron NE; Cotter MA; Dines KC
Diabetologia; 1993 Dec; 36(12):1230-7. PubMed ID: 8307249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
